Pharming Group
Gerrianne Hazewinkel is an accomplished professional in enterprise risk management and environmental, social, and governance (ESG) consulting. Currently serving as an Enterprise Risk Management Consultant for Pharming Group since September 2025 and as a Pecten ESG Practice Consultant since January 2025, Gerrianne also holds the position of Managing Partner at Hazewinkel Risk Consulting BV, established in December 2016. Additional roles include serving as a member of the Supervisory Board for Shell Alumni Network since April 2020, and as a board member at Gewoon Speciaal Onderwijs since January 2022. Previous experience includes key positions in risk management and compliance across prominent companies such as Arcadis and Shell. Gerrianne's educational background includes a Master's degree in Business Economics from Vrije Universiteit Amsterdam, a postgraduate program from Erasmus University Rotterdam, and an FCPA Certificate attained in January 2023.
This person is not in any teams
This person is not in any offices
Pharming Group
Pharming is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. Pharming’s lead product, RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (“HAE”) attacks in patients in Europe, the US, Israel, and South Korea.